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Introduction
B. anthracis, the etiological agent of anthrax, is a zoonotic 
pathogen that can cause life threatening diseases in animals and 
humans.1 Virulent strains of B. anthracis harbor two plasmids, 
pXO1 and pXO2, carrying unique genes that confer toxin pro-
duction and capsule synthesis, respectively.2-4 Due to its possible 
use as an agent for bioterrorism, B. anthracis is one of the most 
feared microorganisms.
The major challenge of developing a reliable assay for the detec-
tion of B. anthracis stems from its high similarity to other strains 
in its genus. B. anthracis is a member of the Bacillus cereus group 
of bacteria (B. cereus sensu lato) which comprises 6 genetically 
related species: B. cereus, B. anthracis, B. thuringiensis, B. mycoi-
des, B. weihanstephanensis, and B. pseudomycoides. An extremely 
high degree of genomic homology exists between B. cereus, 
B. anthracis, and B. thuringiensis, which some authors consider 
genetically just one species.5,6 The main difference between these 
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Bacillus anthracis, the causative agent of anthrax, is a zoonotic pathogen that is relatively common throughout the 
world and may cause life threatening diseases in animals and humans. There are many PcR-based assays in use for the 
detection of B. anthracis. While most of the developed assays rely on unique markers present on virulence plasmids 
pXO1 and pXO2, relatively few assays incorporate chromosomal DNa markers due to the close relatedness of B. anthracis 
to the B. cereus group strains. For the detection of chromosomal DNa, different genes have been used, such as Ba813, 
rpoB, gyrA, plcR, s-layer, and prophage-lambda. Following a review of the literature, an in silico analysis of all signature 
sequences reported for identification of B. anthracis was conducted. Published primer and probe sequences were com-
pared for specificity against 134 available Bacillus spp. genomes. although many of the chromosomal targets evalu-
ated are claimed to be specific to B. anthracis, cross-reactions with closely related B. cereus and B. thuringiensis strains 
were often observed. Of the 35 investigated PcR assays, only 4 were 100% specific for the B. anthracis chromosome. an 
interlaboratory ring trial among five european laboratories was then performed to evaluate six assays, including the 
WhO recommended procedures, using a collection of 90 Bacillus strains. Three assays performed adequately, yielding no 
false positive or negative results. all three assays target chromosomal markers located within the lambdaBa03 prophage 
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species is the presence of unique virulence plasmids. However, 
data gathered in the last decade have shown that B. cereus strains 
that contain anthrax-specific pXO-like plasmids exist7-12 which 
further obscure the much intermixed phylogenetic structure of 
the B. cereus group.
Some PCR-based assays in use for detection of B. anthracis 
rely on plasmid-encoded targets in conjunction with a chromo-
somal marker to correctly differentiate pathogenic from apatho-
genic B. anthracis strains and B. anthracis from non-anthracis 
Bacillus species, respectively (for a review see ref. 13). The impor-
tance of including a chromosomal assay to verify the presence 
of B. anthracis independently of plasmid occurrence was empha-
sized by the discovery of forms of B. anthracis isolates lacking 
plasmids, B. cereus isolates harboring anthrax-like virulence plas-
mids, and pXO2 gene homologs in environmental Bacillus iso-
lates.7-12 Several chromosomal targets have been investigated for 
identification purposes, but most of the markers reported to be 
unique for B. anthracis were in fact common to both B. anthracis 
and a subpopulation of closely related B. cereus and B. thuringi-
ensis strains.13-15 Few chromosomal sequences that provide suf-
ficient polymorphism to unambiguously distinguish B. anthracis 
from its near neighbors have been identified.14,16-22 Some of these 
assays rely upon single-nucleotide differences for discrimination 
and are therefore sensitive to assay conditions and PCR cycling 
parameters. Small alterations in these conditions can result in the 
loss of specificity, especially with hydrolysis probes, i.e., TaqMan 
chemistry.18,23-25
To evaluate the wide range of PCR methods used in laborato-
ries for B. anthracis identification, a computer-based comparative 
analysis of more than 300 PCR-target sequences reported in the 
literature was conducted. All sequences were compared against 
all publicly available Bacillus genomes and sorted for specificity. 
The three assays with highest in silico specificity, together with 
three assays with lower specificity, were evaluated in an interna-
tional ring trial using DNA of Bacillus strains exchanged in the 
framework of the EU AniBioThreat project. The best chromo-
somal signatures for reliable B. anthracis genome detection are 
discussed for the purpose of selecting an assay as international 
standard for B. anthracis detection.
Results
Literature survey of PCR-based detection methods
The literature survey showed that at least 20 different chromo-
somal markers have been described (Table 1).13-15 The first DNA 
signatures that were developed for anthrax PCR detection meth-
ods independently of plasmids occurrence were DNA fragments 
used to genotype B. anthracis. They include the vrrA marker,26-28 
the AC-390 gene,29 and the SG-850/749 fragment.30 These genetic 
markers provide limited specificity and require additional time-
consuming and labor-intensive post-PCR analysis steps. Other 
areas of the chromosome have also been investigated as potential 
DNA-targets for identification purposes, including the so-called 
BA81331-38 and BA5510 sequences,19 genes bclB,39 sap,40,41 saspB,5,42 
and sspE,22,43 the B-type small acid-soluble spore protein gene 
(SASP),44 a glycosyltransferase group 1 family protein,45 a protein 
showing similarities with an abhydrolase,18 and several DNA 
loci located on prophage regions,17 i.e., BA5345,21 BA5357,46 and 
PL3.47 Although most of these regions have been claimed to be 
anthrax-specific, B. cereus strains sometimes yield false-positive 
results.13-15 Finally, a few single nucleotide polymorphisms (SNP) 
have also been considered for PCR markers. Target genes include 
rpoB,24,48-51 gyrA,25,52,53 gyrB,54,55 plc,20,23,53,56 purA,57 and the 16S-
23S rDNA internal spacer sequences.58-60 But, so far, only the 
nonsense mutation in the global regulator PlcR, which controls 
the transcription of secreted virulence factors in B. cereus and 
B. thuringiensis, have proved to be truly unique to B. anthracis 
strains.16,20,59 False-positive signals have sometimes been recorded 
with closely related strains of the B. cereus group using the other 
published SNPs.24,49,52,59,61-63
In silico analysis
About a hundred sequences corresponding to all primers and 
probes currently published were compiled and compared using 
the primer alignment function of the Gegenees software (www.
gegenees.org).64 Each sequence was tested against all available 
Bacillus spp. genomes and scored for specificity (Table 1). Bacillus 
is one of the largest genera represented in the bacterial genome 
database, with about 140 distinct members of the B. cereus group 
sequenced (www.ncbi.nlm.nih.gov).
Excluding SNP discrimination assays, it was found that out 
of the 35 PCR assays analyzed in silico, only four were specific 
for the B. anthracis chromosome, with a minimum unalignment 
value for background genomes higher than zero (Table 1). These 
assays target the markers BA5345,21,65 PL3,47 and BA5357,46 
respectively. Three of these assays are based on hydrolysis probe 
(“TaqMan assay”); the fourth uses SYBR Green chemistry. These 
primer/probe sequences showed a perfect match to all B. anthracis 
genomes, and very poor matches to B. thuringiensis and B. cereus 
strains, including strains that are known to be phylogenetically 
very closely linked to B. anthracis. All other assays were found to 
be prone to false positive identification, as perfect matches were 
found for several B. cereus and B. thuringiensis strains.
To illustrate the complexity of the B. cereus group and why 
PCR-markers cross-react with some B. cereus and B. thuringiensis 
strains, we compared the genomes of 22 strains that were later used 
for PCR assays assessment in the ring trial (see below). Table 2 
shows a similarity matrix that gives a phylogenomic overview of 
the 22 genomes. We considered an 80% average core genome 
similarity as threshold for a strain to be called a near neighbor 
as genomes passing this criterion produced most cross-reactions. 
Assessment of several in silico primer alignments showed that 
the vast majority of the cross reactions occurred within the near-
neighbor group, at least for the better performing assays.
Regarding assays relying upon single-nucleotide differences 
for discrimination, the in silico investigation confirmed that the 
plcR and purA point mutations were unique to B. anthracis strains 
(data not shown). The SNP at position 1668 of gyrA was also 
found to be a relatively specific marker for B. anthracis identi-
fication as only one genome (B. thuringiensis serovar monterrey 
BGSC 4AJ1) contained the C variant specific for B. anthracis. 
Screening other published SNPs resulted in false-positive signals 









































gyrA qPcR p GGGaacaaaT GaTGaTGaTT TcGT Yes 0 >10
(Ba_0006) hP-MGB p acTcTGGGaT TTcaTaTccT TTcGT Yes 0 >10
s cGcaTGacca TaTTc Yes 0 1
antwerpen 
et al.21
Ba5345 qPcR p cGTaaGGaca aTaaaaGccG TTGT Yes 2 2







16s rRNa qPcR s TTaccTcacc aacTaGcTaa TGcGa Yes 0 ~50
Beacon p TTcGGcTGTc acTTaTGGaT G Yes 0 ~50
p TcGGcTacGc aTcGTTGccT TG No 0 ~50
Irenge et al.57
purA qPcR p caacacTTaa aaTTTGTGTT GcTTacaa Yes 0 >10
(Ba_5716) hP-LNa p TcacaTTTcG cTaaaaTGTT TaaGTTTG Yes 0 >10
s TcGaTaacTT TcccaTcGca Yes 1 18
ptsI qPcR p GcTTGacGGa aYTcaTcaaG aGT ND 1 ~40–50
(Ba_4267) hP-LNa p TaTGYcTTGa WGaRcaaGaT GTGTTc ND 3 ~40–50
s GTacacaacT TcGTGcaTT Yes 0 ~40
Vahedi et al.38
Ba813 PcR p aaTGaTaGcT ccTacaTTTG GaG No 3 ~20
(Ba-5031) p TTaaTTcacT TGcaacTGaT GGG Yes 0 1
Qi et al.24
rpoB qPcR p ccaccaacaG TaGaaaaTGc c Yes 0 2
(Ba_0102) FReT p aaaTTTcacc aGTTTcTGGa TcT Yes 0 2
s TccaaaGcGc TaTGaTTTaG caaaTGT Yes 0 4
s GGTcGcTaca aGaTcaacaa GaaGTTacac Yes 0 ~20
Oggioni et al.48
rpoB qPcR p TTGcTTGaaa TTTaTGaGcG TcTac Yes 0 ~50
(Ba_0102) FReT p aTTGTTccTT cTGccGcTaa aa Yes 0 ~50
s TGTaGGTcGc TacaaGaTca acaaG Yes 0 21
s aaGcGcTaTG aTTTaGcaa Yes 0 5
easterday 
et al.20
plcR qPcR p ccaaTcaaTG TcaTacTaTT aaTTTGacac Yes 0 19
(Ba_5595) hP-MGB p aTGcaaaaGc aTTaTacTTG GacaaT Yes 0 8
s caaaGcGcTT aTTcGTaTT Yes 1 25
s aaaGcGcTTc TTcGTaTT No 0 ~30
Lewerin et al.65
Ba_5345 qPcR p GaaGGacGaT acaGacaTTT aTTGG Yes 5 2
(Ba_5345)* sybrGreen p accGcaaGTT GaaTaGcaaG Yes 0 2
Wielinga et al.47
PL3 qPcR p aaaGcTacaa acTcTGaaaT TTGTaaaTTG Yes 5 1
(Ba_5358)* hP p caacGaTGaT TGGaGaTaGa GTaTTcTTT Yes 6 2
s aacaGTacGT TTcacTGGaG caaaaTcaa Yes 4 1
Kim et al.43
sspE qPcR p GaGaaaGaTG aGTaaaaaac aacaa Yes 0 ~50






(Ba-5031) hP-MGB p GGaGGGaaTa caGcaaacac aGa Yes 0 ~15
p TGcaacTGaT GGGaTTTcTT TcT Yes 0 ~15
ND, BLasT could not handle Y, W and R; s, probe; p, primer; np, nested primer; hP, hydrolysis probes; MGB, minor-grove-binding; FReT, hybridization 
probes; RaPD, random amplification of polymorphic DNa; LNa, locked nucleic-acid; GT, glycosyltransferase. *DNa located on prophage region.
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B26 qPcR p TGGcGGaaaa GcTaaTaTaG TaaaGTa Yes 0 7
(Ba_2686) hP-MGB p ccacaTaTcG aaTcTccTGT cTaaaa Yes 0 6
s acTTcTaaaa aGcaGaTaGa aaT Yes 0 7
Ryu et al.41
sap qPcR p caaTcGaaaT GGcTGaccaa a Yes 0 6






rpoB qPcR p ccaccaacaG TaGaaaaTGc c Yes 0 2
(Ba_0102) hP p aaaTTTcacc aGTTTcTGGa TcT Yes 0 2
s acTTGTGTcT cGTTTcTTcG aTccaaaGcG Yes 0 ~40
Luna et al.36
Ba813 qPcR p aaTTTGaaGc aTTaacGaGT T Yes 0 ~20
(Ba-5031) hP p TTcTTTcTGa cTTGGaaTaG c Yes 0 ~20
s GccaGGTTcTa TaccGTaTca Gcaa Yes 0 ~20
Letant et al.46
Ba5357 qPcR p TTTcGaTGaT TTGcaaTGcc Yes 2 10






B-type sasP qPcR p GcTaGTTaTG GTacaGaGTT TGcGac Yes 0 15
(Ba_0524) FReT p ccaTaacTGa caTTTGTGcT TTGaaT No 3 11
s caaGcaaacG cacaaTcaGa aGcTaaG Yes 0 10
s GcGcaaGcTT cTGGTGcTaG c Yes 4 ~40
Jackson et al.27
vrrA PcR p acaacTacca ccGaTGGc Yes 0 ~40
(Ba_4509/11) p TTaTTTaTca TaTTaGTTGG aTTcG Yes 0 32
np TaTGGTTGGT aTTGcTG Yes 0 16
np aTGGTTccGc cTTaTcG Yes 0 32
Ramisse et al.31
Ba813 PcR p TTaaTTcacT TGcaacTGaT GGG Yes 0 1
(Ba-5031) p aacGaTaGcT ccTacaTTTG GaG Yes 0 19
WhO40
s-Layer, sap PcR p cGcGTTTcTa TGGcaTcTcT TcT Yes 0 13
(Ba_0885) p TTcTGaaGcT GGcGTTacaa aT No 2 3
Daffonchio 
et al.30
sG-850/749 RaPD (AluI) p acTGGcTaaT TaTGTaaTG No 2 ~50
(Ba_1584/85) p aTaaTTaTcc aTTGaTTTcG Yes 0 ~30
Wang et al.37
Ba813 microarray p caTTTaGcGa aGaTccaGT Yes 0 ~20
(Ba-5031) p cTTGcTGaTa cGGTaTaGaa c Yes 0 ~20
s TTTTTTTTTT caTTTaGcGa aGaTccaGT Yes 0 ~20
Brightwell 
et al.33
Ba81 PcR p TTaaTTcac TTGcaacTG aTGGG Yes 0 1
(Ba-5031) p aacGaTaGc TccTacaTT TGGaG Yes 0 ~20
Nubel et al.58
16–23s tRNa microarray s GcaacGaGc Gcaaccc Yes 0 ~140
s cTGaGcTaT aGscccaTa No 1 ~80
s ccaTacaaaT TTcaGGaTTT a Yes 0 2
s ccaTacaaaT TTcaGGaTTT Yes 0 2
s caTacaaaTT TcaGGaTTT Yes 0 2
Daffonchio 
et al.59
16–23s tRNa PcR p GaTaTGaTaT aaaTaaaTcG cG No 2 2
p GTGGGTTTcc ccaTTcGG No 0 ~100
ND, BLasT could not handle Y, W and R; s, probe; p, primer; np, nested primer; hP, hydrolysis probes; MGB, minor-grove-binding; FReT, hybridization 










































rpoB PcR p TTcGTccTGT TaTTGcaG Yes 1 ~40
(Ba_0102) p GacGaTcaTY TWGGaaaccG ND ND ND
p GGNGTYTcRa TYGGacacaT ND ND ND
cheun et al.34
Ba813 nested PcR p acTaacGaaT cTTTcaTTTa GcG Yes 0 ~20
(Ba-5031) p aTTGcacTTG caTaaTaTcc TTG Yes 0 ~20
np aacGaTaGcT ccTacaTTTG GaG Yes 0 ~20
np TTaaTTcacT TGcaacTGaT GGG Yes 0 1
s-Layer nested PcR p cGcGTTTcTa TGGcaTcTcTT cT Yes 0 13
(Ba_0885) p TTcTGaaGcT GGcGTTacaa aT No 2 2
np cGGRacaGaa GcaGcaaaa No 1 5
np GcTGTTGGcT caTcaGcTa Yes 0 3
Park et al.55
gyrB PcR p GGTaGaTTaG caGaTTGcTc TTcaaaaGa No 1 12
(Ba_0005) p acGaGcTTTcT caaTaTcaaa aTcTccGc Yes 0 11
Kim et al.45
GT PcR p TcTTcaGTGa caaaaccaca Yes 0 2
(Ba_5519) p caaGaaaTcT TTTTcGaaGG Yes 0 3
Olsen et al.19
tagH qPcR p cTGcaTTGaT aGcaaTTTcT Tca Yes 0 2





s caaTcccTGT TaaTTGacca TTaaGcc Yes 0 2
Leski et al.39
bclB PcR p aGGcccaGaa aaTaTTGGac Yes 0 22
(Ba_2450) p GaGTTccTcc cacaccTGG Yes 0 8
cherif et al.29
ac-390 PcR p GaaaaTGGcc GGaTGaGT No 0 9
(Ba_5406) p GacGTTGaaa caTTTaTGca No 0 11
ND, BLasT could not handle Y, W and R; s, probe; p, primer; np, nested primer; hP, hydrolysis probes; MGB, minor-grove-binding; FReT, hybridization 
probes; RaPD, random amplification of polymorphic DNa; LNa, locked nucleic-acid; GT, glycosyltransferase. *DNa located on prophage region.
Ring trial
The three hydrolysis probe assays with highest specificities in 
the in silico analysis (BA5345, PL3, and BA5357) were evalu-
ated in vitro using a panel of 90 Bacillus strains in a laboratory 
ring-trial performed at 5 European laboratories (RIVM, DTU, 
SVA, ANSES, and CVI). Assays mentioned by the World Health 
Organization (WHO)31,40,44 were also included in the ring trial, 
as well as a hydrolysis probe assay35 that targets the often used 
BA813 marker31-38 (Table 3). The latter marker has shown in 
silico cross-reactions toward the near-neighbor strains in use 
in this trial and was included for this reason. The two WHO 
procedures tested are, respectively, a formerly used conventional 
gel-based PCR assay targeting the S-layer gene sap40 and a dual 
hybridization probes qPCR assay targeting a gene encoding the 
small acid-soluble spore protein SASP.44
Results of the ring trial confirmed the results obtained in the 
in silico analysis (Table 4). The three assays with highest in silico 
specificity (BA5345,21 PL3,47 and BA535746) all performed well 
in the ring trial, with diagnostic sensitivity and specificity values 
close to 1 (Table 5). Furthermore, these assays were found to 
be robust and provided consistent results between laboratories 
(kappa values of 0.9–1.0). All 31 B. anthracis strains were cor-
rectly detected, except in one laboratory that failed to detect one 
sample with a lower DNA content using the BA5345 assay. None 
of the non-anthrax strains gave false-positive results for these 
assays for any of the participating laboratories.
The results obtained using the S-layer,40 BA813,35 and SASP44 
assays displayed a lower agreement among laboratories (k values 
of 0.5–0.8). In general, the three methods had relative low diag-
nostic sensitivity and specificity compared with the BA5345, PL3, 
and BA5357 assays, indicating that these methods have a lower 
performance both in detecting B. anthracis in truly contaminated 
samples and in declaring truly non-contaminated samples as free 
of B. anthracis. Although the BA813 assay was found to be quite 
effective in identifying true B. anthracis strains—except for labo-
ratory 2, which failed to detect two strains—it yielded a number 
of false-positive results (ranging from 11 to 23 strains) in all labo-
ratories. As for the former WHO recommended S-layer assay,40 
this conventional PCR method was apparently not as sensitive as 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































all laboratories. In contrast, higher specificity (specificity rang-
ing from 0.88 to 0.95, depending on laboratory, Table 5) was 
obtained with the current WHO recommended SASP assay.44 
This assay correctly identified most of the closely related strains, 
even though improper but late amplifications were sporadically 
observed for a few strains (ranging from 3 to 5). All B. anthra-
cis strains were tested PCR-positive by two of the three labora-
tories that had succeeded to implement the assay on their PCR 
platforms. The WHO protocol relies on fluorescence resonance 
energy transfer (FRET) probes chemistry, but not all real-time 
PCR instruments have detection systems including a channel 
designated for FRET experiments. The third laboratory equipped 
with FRET-capabilities failed to detect five samples with lower 
DNA concentration (Table 4).
Limit of detection of the PL3 assay
In order to propose a single reference method for B. anthra-
cis chromosome detection to diagnostic laboratories through-
out Europe, we further assessed the laboratory sensitivity of 
one of the best performing assays identified in this work, the 
PL3 assay.47 Serial dilutions of genomic DNA from B. anthracis 
strain 17JB were tested to determine the lowest concentration of 
DNA that could be detected at 95% probability. The detection 
limit (LOD
PCR
 at 95% confidence interval) was found to be 2 
genome equivalents. Performance in artificially contaminated 
organs (wild boar spleen) was also examined using 10-fold dilu-
tions of calibrated suspensions of vegetative cells. Non-inoculated 
samples were confirmed to be negative. A reproducible detection 
(100%, n = 9) of samples containing 11 vegetative cells/PCR was 
observed, corresponding to 103 B. anthracis CFU per ml of spleen 
homogenates. Samples containing fewer targets (i.e., 102 CFU/
ml) could be sporadically detected (data not shown).
Discussion
PCR-based identification assays are fast and sensitive meth-
ods, widely used in food, clinical or veterinary laboratories to 
detect the presence of pathogens or to confirm species identity. 
Reliable detection requires the selection of primers and probes 
that hybridize efficiently and specifically with DNA from 
the targeted bacterium, in order to prevent false negative or 
















dhp61_183–113F cGTaaGGaca aTaaaaGccG TTGT 0.9
96
15 s 95 °c
1 min 55 °c
45× 20dhp61_183–208R cGaTacaGac aTTTaTTGGG aacTacac 0.3




PL3_f aaaGcTacaa acTcTGaaaT TTGTaaaTTG 0.2
139
5 s 95 °c
35 s 60 °c
45× 20PL3_r caacGaTGaT TGGaGaTaGa GTaTTcTTT 0.2




Forward TTTcGaTGaT TTGcaaTGcc 1
105
5 s 95 °c
20 s 60 °c
45× 20Reverse TccaaGTTac aGTGTcGGca TaTT 1




Upper 391–413 cGcGTTTcTa TGGcaTcTcT TcT 0.2
639
30 s 95 °c
30 s 55 °c
30 s 72 °c
30× 20
Lower 1029–1008 TTcTGaaGcT GGcGTTacaa aT 0.2
coker35 Ba813
Ba813-FP GGaGGGaaTa caGcaaacac aGa 16
123
15 s 95 °c
1 min 60 °c








aNT-F GcTaGTTaTG GTacaGaGTT TGcGac 0.5
10 s 95 °c
20 s 57 °c
30 s 72 °c
45× 20
aNT-amt ccaTaacTGa caTTTGTGcT TTGaaT 0.5
aNT-FL caaGcaaacG cacaaTcaGa aGcTaaG-FL 0.2
aNT-Lc:Red640 Lc ReD640-GcGcaaGcTT cTGGTGcTaG c-P 0.2
Iac Bfp




aBbfp_R GcTcaGGGcG GacTG 0.2
aBbfp_Tq cGacc acTaccaGca Gaacacc 0.2
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 5. Diagnostic sensitivity (se) and specificity (sP) values for the different assays and laboratories
PCR assay Values for indicated laboratory # (95% confidence limits)
1 2 3 4 5
SE SP SE SP SE SP SE SP SE SP
Ba5345
1.00 0.98 0.94 1.00 1.00 1.00 1.00 1.00 1.00 0.97
(0.89–1) (0.91–1) (0.79–0.99) (0.94–1) (0.89–1) (0.94–1) (0.89–1) (0.94–1) (0.89–1) (0.88–1)
PL3
1.00 0.97 1.00 0.98 1.00 1.00 1.00 1.00 1.00 0.97
(0.89–1) (0.88–1) (0.89–1) (0.91–1) (0.89–1) (0.94–1) (0.89–1) (0.94–1) (0.89–1) (0.88–1)
Ba5357
1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.95
(0.89–1) (0.94–1) (0.89–1) (0.94–1) (0.89–1) (0.94–1) (0.89–1) (0.94–1) (0.89–1) (0.86–0.99)
sap
(s-layer)
0.97 0.69 0.52 0.81 1.00 0.56 1.00 0.69 1.00 0.58
(0.83–1) (0.56–0.81) (0.33–0.70) (0.69–0.90) (0.89–1) (0.42–0.69) (0.89–1) (0.56–0.81) (0.89–1) (0.44–0.70)
Ba813
0.71 0.93 0.52 0.92 0.94 0.86 0.97 0.92 0.97 0.75
(0.52–0.86) (0.84–0.98) (0.33–0.70) (0.81–0.97) (0.79–0.99) (0.75–0.94) (0.83–1) (0.81–0.97) (0.83–1) (0.62–0.85)
B-type sasP




(0.89–1.0) (0.84-.98) (0.66-.95) (0.86-.99) (0.89-.00) (0.77-.95)
nd, not determined
false-positive results. For the almost clonal species of B. anthracis, 
the selection of robust DNA signature sequences for the develop-
ment of PCR assays has proven to be a very difficult task since 
few of the investigated markers proved to be truly unique for the 
species. At present, only three chromosomal features appeared 
to be useful to differentiate B. anthracis from the rest of the 
B. cereus group at the genetic level: (1) being part of the clonal 
cluster made up of highly monomorphic B. anthracis strains, as 
analyzed by MLST, MLVA or similar methods; (2) carrying a 
nonsense mutation at nucleotide position 640 of the plcR gene, 
introducing a premature TAA stop codon; and (3) presence of a 
unique combination of four excision-proficient, lambdoid pro-
phages (lambda01–04).4,16,66
An unexpectedly high amount of PCR assays (~88 %) were 
found to be unspecific for B. anthracis. This is mostly because 
not much was known about the genetically closely related strains 
until the recent rapid increase in available genome sequences. 
The increasing use of Next Generation Sequencing technologies 
in systematic characterization of bacterial genomes has offered a 
powerful approach for large-scale genome comparisons and iden-
tification of specific DNA signatures. This is illustrated by the 
current study in which a thorough in silico analysis of published 
PCR assays for the detection of B. anthracis was possible due 
to the availability of manifold genome sequences. Conclusions 
drawn from this in silico analysis of the full set of Bacillus spp. 
genomes published to date were the following:
1) There was no PCR assay with superior specificity for any 
common target carried by the pXO1 or pXO2 virulence plasmids 
(lef, cya, pag, and cap), since several B. cereus strains were found 
to contain pXO-like plasmids carrying highly similar genes (data 
not shown), as was previously reported by others.7-12
2) Only two single-nucleotide differences appeared to be reli-
able markers for the specific identification of B. anthracis: a vari-
ant at nucleotide position 640 in the plcR gene or at position 1050 
in the purA gene.
3) The four highly specific assays identified in silico (i.e., 
Antwerpen, Lewerin, Létant, and Wielinga) target three dif-
ferent loci located within the lambdaBa03 prophage region 
(ranging from BA5339 to BA5363 loci in the Ames annotated 
genome). All other markers that had been thought to discrimi-
nate B. anthracis from other B. cereus group bacteria were found 
in at least some closely related strains and could therefore result 
in erroneous species attribution, as exemplified by the BA813-
targeted assays or the S-layer assay.40
Except for the recent SASP assay,44 most of the published 
assays gave poor results in the in silico analysis (Table 1), includ-
ing those referred to in the Terrestrial Manual of OIE,67 i.e., 
Jackson et al.27 and Ramisse et al.31 However, to our knowledge, 
this is the first study addressing the in vitro evaluation of the 
SASP genomic markers. Our results should be confirmed on 
a larger panel of Bacillus strains to enable clear conclusions. 
Nevertheless, when standardizing PCR based detection methods 
for B. anthracis, the latter assay might be problematic with regard 
to its ease of implementation. The WHO protocol is based on a 
hybridization probes format for DNA detection and quantifica-
tion by real-time PCR, and only a part of the qPCR instruments 
on the market currently includes detection system with decou-
pled excitation and emission filter channels that allow the use of 
hybridization probes (FRET) chemistry.68 Hydrolysis probes are 
more commonly applied and thus form an alternative that should 
be more universally applicable.
Although excision proficient prophage sequences are generally 
not considered useful targets for bacterial identification because 
of their instability, the persistent presence of the four prophage 
regions in all B. anthracis genomes can be advantageously uti-
lized for the definitive discrimination of B. anthracis from other 
B. cereus group bacteria.66 Given the high impact of the anthrax 
identification issue, one must be cautious and avoid relying solely 
on assays based on SNP discrimination. Such assays are more sen-
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signature sequences, and the occurrence of false positive signals 
from B. cereus strains caused by mispriming is more likely. Even 
though various techniques have been evaluated to enhance the 
specificity of SNP-based PCR assays (including TaqMan mis-
match amplification mutation assay,23 restriction site insertion-
PCR,56 tentacle or locked nucleic acids probes-based PCR25 or high 
resolution melting (HRM)-PCR53), they are neither as robust nor 
as user friendly as assays based on unique signature sequences. The 
chromosomal markers BA5345 (Antwerpen), PL3 (Wielinga), or 
BA5357 (Letant), enable unambiguous identification of B. anthra-
cis strains, including plasmid-cured isolates. Moreover, the PL3 
assay was confirmed to be sensitive enough to be used in biological 
samples. High diagnostic sensitivity of the assay reduces the occur-
rence of false-negative results, which can be further reduced by 
the use of an internal control to prevent pipetting errors. It should 
be emphasized that one of these assays should be implemented in 
conjunction with plasmid-encoded targets in B. anthracis-specific 
PCR methods to discriminate non-virulent from virulent strains.
In conclusion, this study highlights the importance of ana-
lyzing the diagnostic sensitivity and specificity of PCR assays 
designed for detection of B. anthracis, as many of particularly 
the older protocols produce both false negative and false-positive 
results. This is important with regard to the aim of standard-
ization of a PCR assay for B. anthracis detection. Even though 
only slight differences regarding the analytical sensitivity were 
observed between the three highly specific chromosomal assays 
during the ring-trial, we propose the robust and sensitive PL3 
assay as possible European standard to harmonize and improve 
PCR methods for detection of anthrax in animal, feed, environ-
mental, and food samples based on results of this study.
Materials and Methods
Strains
DNA from a total of 90 Bacillus strains were used in this 
study, including 31 B. anthracis isolates, 44 strains of B. cereus or 
B. thuringiensis, and 15 strains encompassing 10 other bacterial 
species (Table 4). Strains came from the collections of Bacilli of 
the different partners: Anses (n = 27), SVA (n = 22), CVI (n = 9) 
and RIVM (n = 32). Of the 90 B. cereus group strains used for in 
vitro studies, 22 had publicly available whole genome sequences 
(Table 2), including 11 B. cereus or B. thuringiensis strains closely 
related to B. anthracis (Table 2) and reported as near-neighbors 
based on multilocus sequence typing analysis.16 All DNA sam-
ples were randomly coded and sent to each of the 5 participating 
laboratories.
DNA extraction procedures
At Anses, B. anthracis suspensions were incubated at 100 °C in 
boiling water for 20 min. After cooling and centrifugation, via-
bility testing was performed to verify absence of live B. anthracis. 
DNA from artificially contaminated samples was further puri-
fied using the High Pure PCR template Preparation Kit from 
Roche according to the manufacturer’s recommendations. DNA 
from non-pathogenic non-B. anthracis bacilli cultures was alter-
natively extracted using a 200 μl aliquot of InstaGeneTM Matrix 
as described by the supplier (Bio-Rad Laboratories).
At CVI, bacterial suspensions were inactivated at 100 °C for 
10 min and tested for absence of viable B. anthracis by plating 
aliquots on nutrient agar petri dishes. DNA was purified using 
the QIAamp DNA Mini Kit (Qiagen Benelux).
At RIVM, bacteria suspensions were incubated at 100 °C for 
30 min, centrifuged at maximum speed for 1 min and the result-
ing lysates were transferred to a 0.22 μm sterile Ultrafree-MC 
spin filter (Millipore). The spin filter was then centrifuged for 
4 min at maximum speed to clean the DNA lysate from left over 
cell debris. DNA lysates from B. anthracis and non-pathogenic 
bacteria were further purified or isolated, respectively using the 
NucliSENS Magnetic Extraction reagents (bioMerieux) follow-
ing the manufacturer instructions.
At SVA, bacterial cultures were centrifuged and DNA 
extracted from the pellet using the MasterPure Gram positive 
kit (Epicenter Biotechnologies). The DNA was taken out of 
the BSL-3 facility by first passing it through an Ultrafree-MC 
0.22 μm sterile filter (Merck Millipore).
Internal amplification control
A fragment of the blue fluorescent protein gene (bfp) was 
used as an internal amplification control (IAC). The IAC 
primers and probe were designed such that they do not inter-
act with any of the primers and probes from the tested assays. 
Oligonucleotides design was performed by using the software 
package Visual Oligonucleotide Modeling Platform version 6 
(DNA Software Inc.). The primers and probe were the following: 
ABbfp_F (5′-TCATGGCCGA CAAGCAGAA-3′), ABbfp_R 
(5′-GCTCAGGGCG GACTG-3′), and ABbfp_Tq (5′-Cy5-
CGACCACTAC CAGCAGAACA CC-BHQ2-3′). Amplicons 
from the bfp gene were produced by using conventional PCR 
and were purified by using the Qiagen PCR purification kit. 
The amount of amplicons that need to be added to samples to 
obtain suitable Cq values for use as internal control was deter-
mined empirically from 10-fold serial dilutions. The developed 
real-time qPCR assays were used to determine the amplicon dilu-
tion needed for a Cq value between 32 and 35.
Conventional and real-time qPCR conditions
Participating laboratories were asked to investigate the com-
plete set of blinded samples using the PCR platforms available 
at their institute. Real-time qPCR and conventional thermo-
cyclers used were the following: Mx3005p (Stratagene); ABI 
7500 Fast, StepOnePlus or AB9700 (Applied BioSystems); 
LightCycler 2.0 or LightCycler 480 (Roche Applied Science); 
C1000, iCycler or MyCycler (BioRad). Primers and probes were 
synthesized by each laboratory’s usual suppliers (Eurogentec, 
Metabion, Sigma or Eurofins MWG operon). Total PCR reac-
tion volume (20 μl) and template volume (2 μl of Bacillus DNA 
and 2 μl of the IAC DNA) were kept constant. Each labora-
tory also used the same qPCR kits and DNA polymerases as in 
their routine diagnostic activities. Five different commercially 
available or custom-made PCR kits (i.e., Taqman Universal 
PCR Master mix [Life Technologies], PerfeCta multiplex super-
mix [Quanta BioSciences], iQ Multiplex Powermix [Bio-Rad], 
VeriQuest qPCR fast master mix [affymetrix], and LightCycler 
FastStart DNA Master HybProbe [Roche Applied Science]) and 
























Multiplex Super-mix, Tth DNA polymerase [Roche] in a cus-
tom-made mix [based on ref. 68], Go Taq DNA polymerase 
[Promega]) were used following manufacturer’s instructions. The 
cycling program and primers/probe concentrations for each assay 
were those described in their original publication (as indicated 
in Table 3).
In silico analysis
Gegenees (http://www.gegenees.org) is open software that 
uses a fragmented alignment approach for the comparative anal-
ysis of hundreds of microbial genomes.64 The genomes are frag-
mented and compared, all against all, by a multithreaded BLAST 
control engine. Each data point connecting two genomes is rep-
resented by a score. Although this genome alignment and data 
mining is the main application of Gegenees, it is also equipped 
with a primer alignment function that facilitates the alignment of 
several primers against a large amount of genomes for specificity 
testing.
The FTP-function of Gegenees was used to download all the 
available Bacillus spp. genomes from NCBI Genomes which, at 
the time of the study, amounted to 134 genomes. All primer/
probe sequences from the literature survey were aligned to the 
134 genomes with a short-sequence-setting (i.e., word length 
of 7) for the BLAST+ algorithm and the alignments were then 
sorted according to their “unalignment index”. The unalignment 
index is the sum of non-aligned nucleotides and reported mis-
matches. A minimal unalignment index value of 0 for a primer 
corresponds to perfect sequence match with the genome the 
primer aligned to. Results have been acquired for all published 
sequences, regardless of the kind of assay reported (e.g., real-time 
qPCR, conventional PCR, LAMP, microarray, etc.) or targets 
used (pXO1-, pXO2-plasmid, or chromosomal DNA). Only data 
from chromosomal markers (n = 35) are reported in the present 
study (Table 1).
To illustrate the relatedness of the B. cereus group strains 
used in this study to B. anthracis, a whole genome comparison 
of the 22 available sequenced whole genome genomes was also 
performed (Table 2). Gegenees was set to perform an all-all frag-
mented alignment using 500 bp fragments. The average genomic 
core genome similarity values were also calculated (Table 2).
Ring trial
A ring trial was performed among 5 European laboratories 
in the framework of the EU AniBioThreat project (http://www.
anibiothreat.com). Six published PCR-assays targeting different 
B. anthracis chromosomal markers were evaluated in vitro. The 
most specific methods according to in silico analysis21,46,47 were 
compared with the assays recommended by the WHO40,44 and 
a single assay targeting BA813.35 Ninety blinded DNA samples 
were exchanged between partners and an IAC was distributed. A 
detailed standard operative protocol describing how to conduct 
and perform the ring trial was set up after consultation of all 
participating laboratories. Samples were re-tested in case of IAC 
inhibition. A reporting form file was distributed among partici-
pants to record the results.
Diagnostic sensitivity and specificity for all assays and labora-
tories were calculated together with the kappa values in SAS 9.1.3 
(SAS Institute Inc.) using the FREQ procedure. The sensitivity 
was defined as the fraction of positive DNA samples which were 
known to contain B. anthracis (as determined by standard meth-
ods used by the different culture collections) that gave a positive 
PCR results by the different methods. Specificity was defined as 
the fraction of negative DNA samples which were known not to 
contain B. anthracis DNA that gave a negative PCR results by 
the different PCR methods. Kappa values measure the level of 
agreement between results obtained by the different participating 
laboratories and PCR methods combinations. The calculation is 
based on the difference between how much agreement is actually 
present (“observed” agreement) compared with how much agree-
ment would be expected to be present by chance alone (“expected” 
agreement). A kappa value of 1 indicates perfect agreement, 
whereas a kappa of 0.5 indicates moderate agreement and a value 
of 0 indicates that the apparent agreement is only due to chance.69
Detection limit of the PL3 assay
The limit of detection of the PL3 assay47 was determined by 
using serial dilutions of genomic DNA from B. anthracis strain 
17JB. Six dilutions around the expected limit of detection (cor-
responding to 5, 2, 1, 0.5, 0.2, and 0.1 genome equivalents) 
were used to calculate a precise LOD
PCR
 value (3 runs, 24 rep-
licates for each dilution).70 Genomic DNA was quantified by 
fluorimetry using the Qubit® 2.0 Fluorometer (Invitrogen). The 
number of genomic copies was calculated as follows: m = n × 
(1.013 × 10-21 g/bp), where m is the mass and n is the number of 
base pairs.
Wild boar spleen homogenates were used to assess the sen-
sitivity of the assay in biological samples. Portions of 1 ml were 
artificially inoculated in triplicate at five contamination lev-
els with calibrate suspensions of vegetative cells (ranging from 
5.5 × 101 to 5.5 × 105 CFU/ml) from strain 17JB as previously 
described.53 Samples were then incubated at 56 °C for 1 h in the 
presence of proteinase K and inactivated for 20 min at 100 °C in 
boiling water. After cooling and centrifugation, viability testing 
was performed to verify depletion of live B. anthracis. DNA was 
then extracted from 200 μl aliquots using the High Pure PCR 
Template Preparation Kit (Roche). Two microliter aliquots of the 
eluted DNA were used as template. The exact numbers of cells 
introduced into spleen homogenates were determined a posteriori 
by plating.
Disclosure of Potential Conflicts of Interest
No potential conflicts of interest were disclosed.
Acknowledgments
Pia Engelsmann, DTU, is acknowledged for excellent techni-
cal assistance. This research was supported by/executed in the 
framework of the EU-project AniBioThreat (Grant Agreement: 
Home/2009/ISEC/AG/191) with the financial support from 
the Prevention of and Fight against Crime Programme of the 
European Union, European Commission—Directorate General 
Home Affairs. This publication reflects the views only of the 
authors, and the European Commission cannot be held respon-
sible for any use that may be made of the information contained 
























14 Virulence Volume 4 Issue 8
References
1. Mock M, Fouet A. Anthrax. Annu Rev Microbiol 
2001; 55:647-71; PMID:11544370; http://dx.doi.
org/10.1146/annurev.micro.55.1.647
2. Okinaka R, Cloud K, Hampton O, Hoffmaster 
A, Hill K, Keim P, Koehler T, Lamke G, Kumano 
S, Manter D, et al. Sequence, assembly and analy-
sis of pX01 and pX02. J Appl Microbiol 1999; 
87:261-2; PMID:10475962; http://dx.doi.
org/10.1046/j.1365-2672.1999.00883.x
3. Okinaka RT, Cloud K, Hampton O, Hoffmaster AR, 
Hill KK, Keim P, Koehler TM, Lamke G, Kumano 
S, Mahillon J, et al. Sequence and organization of 
pXO1, the large Bacillus anthracis plasmid harboring 
the anthrax toxin genes. J Bacteriol 1999; 181:6509-
15; PMID:10515943
4. Read TD, Peterson SN, Tourasse N, Baillie LW, 
Paulsen IT, Nelson KE, Tettelin H, Fouts DE, Eisen 
JA, Gill SR, et al. The genome sequence of Bacillus 
anthracis Ames and comparison to closely related 
bacteria. Nature 2003; 423:81-6; PMID:12721629; 
http://dx.doi.org/10.1038/nature01586
5. Marston CK, Gee JE, Popovic T, Hoffmaster 
AR. Molecular approaches to identify and dif-
ferentiate Bacillus anthracis from phenotypically 
similar Bacillus species isolates. BMC Microbiol 
2006; 6:22; PMID:16515693; http://dx.doi.
org/10.1186/1471-2180-6-22
6. Helgason E, Okstad OA, Caugant DA, Johansen 
HA, Fouet A, Mock M, Hegna I, Kolstø AB. 
Bacillus anthracis, Bacillus cereus, and Bacillus 
thuringiensis--one species on the basis of genetic 
evidence. Appl Environ Microbiol 2000; 66:2627-
30; PMID:10831447; http://dx.doi.org/10.1128/
AEM.66.6.2627-2630.2000
7. Turnbull PC, Hutson RA, Ward MJ, Jones MN, 
Quinn CP, Finnie NJ, Duggleby CJ, Kramer JM, 
Melling J. Bacillus anthracis but not always anthrax. 
J Appl Bacteriol 1992; 72:21-8; PMID:1541596; 
ht tp : //d x .doi .org /10.1111/j.1365-2672 .1992 .
tb04876.x
8. Pannucci J, Okinaka RT, Sabin R, Kuske CR. Bacillus 
anthracis pXO1 plasmid sequence conservation 
among closely related bacterial species. J Bacteriol 
2002; 184:134-41; PMID:11741853; http://dx.doi.
org/10.1128/JB.184.1.134-141.2002
9. Pannucci J, Okinaka RT, Williams E, Sabin R, 
Ticknor LO, Kuske CR. DNA sequence conservation 
between the Bacillus anthracis pXO2 plasmid and 
genomic sequence from closely related bacteria. BMC 
Genomics 2002; 3:34; PMID:12473162; http://
dx.doi.org/10.1186/1471-2164-3-34
10. Hoffmaster AR, Ravel J, Rasko DA, Chapman 
GD, Chute MD, Marston CK, De BK, Sacchi CT, 
Fitzgerald C, Mayer LW, et al. Identification of 
anthrax toxin genes in a Bacillus cereus associated with 
an illness resembling inhalation anthrax. Proc Natl 
Acad Sci U S A 2004; 101:8449-54; PMID:15155910; 
http://dx.doi.org/10.1073/pnas.0402414101
11. Klee SR, Brzuszkiewicz EB, Nattermann H, 
Brüggemann H, Dupke S, Wollherr A, Franz T, Pauli 
G, Appel B, Liebl W, et al. The genome of a Bacillus 
isolate causing anthrax in chimpanzees combines 
chromosomal properties of B. cereus with B. anthra-
cis virulence plasmids. PLoS One 2010; 5:e10986; 
PMID:20634886; http://dx.doi.org/10.1371/jour-
nal.pone.0010986
12. Klee SR, Ozel M, Appel B, Boesch C, Ellerbrok H, 
Jacob D, Holland G, Leendertz FH, Pauli G, Grunow 
R, et al. Characterization of Bacillus anthracis-like 
bacteria isolated from wild great apes from Cote 
d’Ivoire and Cameroon. J Bacteriol 2006; 188:5333-
44; PMID:16855222; http://dx.doi.org/10.1128/
JB.00303-06
13. Edwards KA, Clancy HA, Baeumner AJ. Bacillus 
anthracis: toxicology, epidemiology and current 
rapid-detection methods. Anal Bioanal Chem 
2006; 384:73-84; PMID:16283259; http://dx.doi.
org/10.1007/s00216-005-0090-x
14. Irenge LM, Gala JL. Rapid detection methods 
for Bacillus anthracis in environmental samples: a 
review. Appl Microbiol Biotechnol 2012; 93:1411-
22; PMID:22262227; http://dx.doi.org/10.1007/
s00253-011-3845-7
15. Rao SS, Mohan KV, Atreya CD. Detection technolo-
gies for Bacillus anthracis: prospects and challenges. J 
Microbiol Methods 2010; 82:1-10; PMID:20399814; 
http://dx.doi.org/10.1016/j.mimet.2010.04.005
16. Kolstø AB, Tourasse NJ, Økstad OA. What sets 
Bacillus anthracis apart from other Bacillus spe-
cies? Annu Rev Microbiol 2009; 63:451-76; 
PMID:19514852; http://dx.doi.org/10.1146/
annurev.micro.091208.073255
17. Radnedge L, Agron PG, Hill KK, Jackson PJ, Ticknor 
LO, Keim P, Andersen GL. Genome differences that 
distinguish Bacillus anthracis from Bacillus cereus 
and Bacillus thuringiensis. Appl Environ Microbiol 
2003; 69:2755-64; PMID:12732546; http://dx.doi.
org/10.1128/AEM.69.5.2755-2764.2003
18. Bode E, Hurtle W, Norwood D. Real-time PCR 
assay for a unique chromosomal sequence of 
Bacillus anthracis. J Clin Microbiol 2004; 42:5825-
31; PMID:15583318; http://dx.doi.org/10.1128/
JCM.42.12.5825-5831.2004
19. Olsen JS, Skogan G, Fykse EM, Rawlinson EL, 
Tomaso H, Granum PE, Blatny JM. Genetic dis-
tribution of 295 Bacillus cereus group members 
based on adk-screening in combination with MLST 
(Multilocus Sequence Typing) used for validat-
ing a primer targeting a chromosomal locus in B. 
anthracis. J Microbiol Methods 2007; 71:265-74; 
PMID:17997177; http://dx.doi.org/10.1016/j.
mimet.2007.10.001
20. Easterday WR, Van Ert MN, Simonson TS, Wagner 
DM, Kenefic LJ, Allender CJ, Keim P. Use of single 
nucleotide polymorphisms in the plcR gene for specific 
identification of Bacillus anthracis. J Clin Microbiol 
2005; 43:1995-7; PMID:15815042; http://dx.doi.
org/10.1128/JCM.43.4.1995-1997.2005
21. Antwerpen MH, Zimmermann P, Bewley K, 
Frangoulidis D, Meyer H. Real-time PCR sys-
tem targeting a chromosomal marker specific for 
Bacillus anthracis. Mol Cell Probes 2008; 22:313-
5; PMID:18602986; http://dx.doi.org/10.1016/j.
mcp.2008.06.001
22. Janse I, Hamidjaja RA, Bok JM, van Rotterdam BJ. 
Reliable detection of Bacillus anthracis, Francisella 
tularensis and Yersinia pestis by using multiplex qPCR 
including internal controls for nucleic acid extraction 
and amplification. BMC Microbiol 2010; 10:314; 
PMID:21143837
23. Easterday WR, Van Ert MN, Zanecki S, Keim 
P. Specific detection of bacillus anthracis using a 
TaqMan mismatch amplification mutation assay. 
Biotechniques 2005; 38:731-5; PMID:15945372; 
http://dx.doi.org/10.2144/05385ST03
24. Qi Y, Patra G, Liang X, Williams LE, Rose S, 
Redkar RJ, DelVecchio VG. Utilization of the rpoB 
gene as a specific chromosomal marker for real-time 
PCR detection of Bacillus anthracis. Appl Environ 
Microbiol 2001; 67:3720-7; PMID:11472954; http://
dx.doi.org/10.1128/AEM.67.8.3720-3727.2001
25. Satterfield BC, Kulesh DA, Norwood DA, Wasieloski 
LP Jr., Caplan MR, West JA. Tentacle Probes: dif-
ferentiation of difficult single-nucleotide polymor-
phisms and deletions by presence or absence of a 
signal in real-time PCR. Clin Chem 2007; 53:2042-
50; PMID:17932130; http://dx.doi.org/10.1373/
clinchem.2007.091488
26. Andersen GL, Simchock JM, Wilson KH. 
Identification of a region of genetic variability 
among Bacillus anthracis strains and related species. 
J Bacteriol 1996; 178:377-84; PMID:8550456
27. Jackson PJ, Hugh-Jones ME, Adair DM, Green 
G, Hill KK, Kuske CR, Grinberg LM, Abramova 
FA, Keim P. PCR analysis of tissue samples from 
the 1979 Sverdlovsk anthrax victims: the presence 
of multiple Bacillus anthracis strains in different 
victims. Proc Natl Acad Sci U S A 1998; 95:1224-
9; PMID:9448313; http://dx.doi.org/10.1073/
pnas.95.3.1224
28. Keim P, Price LB, Klevytska AM, Smith KL, 
Schupp JM, Okinaka R, Jackson PJ, Hugh-Jones 
ME. Multiple-locus variable-number tandem 
repeat analysis reveals genetic relationships within 
Bacillus anthracis. J Bacteriol 2000; 182:2928-
36; PMID:10781564; http://dx.doi.org/10.1128/
JB.182.10.2928-2936.2000
29. Cherif A, Borin S, Rizzi A, Ouzari H, Boudabous 
A, Daffonchio D. Characterization of a repetitive 
element polymorphism-polymerase chain reaction 
chromosomal marker that discriminates Bacillus 
anthracis from related species. J Appl Microbiol 
2002; 93:456-62; PMID:12174044; http://dx.doi.
org/10.1046/j.1365-2672.2002.01712.x
30. Daffonchio D, Borin S, Frova G, Gallo R, Mori E, 
Fani R, Sorlini C. A randomly amplified polymorphic 
DNA marker specific for the Bacillus cereus group 
is diagnostic for Bacillus anthracis. Appl Environ 
Microbiol 1999; 65:1298-303; PMID:10049896
31. Ramisse V, Patra G, Garrigue H, Guesdon JL, 
Mock M. Identification and characterization 
of Bacillus anthracis by multiplex PCR analy-
sis of sequences on plasmids pXO1 and pXO2 
and chromosomal DNA. FEMS Microbiol Lett 
1996; 145:9-16; PMID:8931320; http://dx.doi.
org/10.1111/j.1574-6968.1996.tb08548.x
32. Ramisse V, Patra G, Vaissaire J, Mock M. The Ba813 
chromosomal DNA sequence effectively traces the 
whole Bacillus anthracis community. J Appl Microbiol 
1999; 87:224-8; PMID:10475954; http://dx.doi.
org/10.1046/j.1365-2672.1999.00874.x
33. Brightwell G, Pearce M, Leslie D. Development 
of internal controls for PCR detection of Bacillus 
anthracis. Mol Cell Probes 1998; 12:367-77; 
PMID:9843654; http://dx.doi.org/10.1006/
mcpr.1998.0195
34. Cheun HI, Makino SI, Watarai M, Shirahata T, 
Uchida I, Takeshi K. A simple and sensitive detection 
system for Bacillus anthracis in meat and tissue. J Appl 
Microbiol 2001; 91:421-6; PMID:11556906; http://
dx.doi.org/10.1046/j.1365-2672.2001.01395.x
35. Coker PR, Smith KL, Fellows PF, Rybachuck G, 
Kousoulas KG, Hugh-Jones ME. Bacillus anthracis 
virulence in Guinea pigs vaccinated with anthrax 
vaccine adsorbed is linked to plasmid quantities 
and clonality. J Clin Microbiol 2003; 41:1212-
8; PMID:12624053; http://dx.doi.org/10.1128/
JCM.41.3.1212-1218.2003
36. Luna VA, King D, Davis C, Rycerz T, Ewert M, 
Cannons A, Amuso P, Cattani J. Novel sample 
preparation method for safe and rapid detection of 
Bacillus anthracis spores in environmental powders 
and nasal swabs. J Clin Microbiol 2003; 41:1252-
5; PMID:12624060; http://dx.doi.org/10.1128/
JCM.41.3.1252-1255.2003
37. Wang SH, Wen JK, Zhou YF, Zhang ZP, Yang 
RF, Zhang JB, Chen J, Zhang XE. Identification 
and characterization of Bacillus anthracis by mul-
tiplex PCR on DNA chip. Biosens Bioelectron 

























38. Vahedi F, Moazeni Jula G, Kianizadeh M, Mahmoudi 
M. Characterization of Bacillus anthracis spores iso-
lates from soil by biochemical and multiplex PCR 
analysis. East Mediterr Health J 2009; 15:149-56; 
PMID:19469438
39. Leski TA, Caswell CC, Pawlowski M, Klinke DJ, 
Bujnicki JM, Hart SJ, Lukomski S. Identification and 
classification of bcl genes and proteins of Bacillus cereus 
group organisms and their application in Bacillus 
anthracis detection and fingerprinting. Appl Environ 
Microbiol 2009; 75:7163-72; PMID:19767469; 
http://dx.doi.org/10.1128/AEM.01069-09
40. WHO. Guidelines for the surveillance and control of 
anthrax in human and animals. In: Turnbull PC, ed. 
Geneva, Switzerland: WHO Press, 1998.
41. Ryu C, Lee K, Yoo C, Seong WK, Oh HB. Sensitive 
and rapid quantitative detection of anthrax spores iso-
lated from soil samples by real-time PCR. Microbiol 
Immunol 2003; 47:693-9; PMID:14605435
42. Hoffmaster AR, Meyer RF, Bowen MD, Marston 
CK, Weyant RS, Thurman K, Messenger SL, Minor 
EE, Winchell JM, Rassmussen MV, et al. Evaluation 
and validation of a real-time polymerase chain reac-
tion assay for rapid identification of Bacillus anthracis. 
Emerg Infect Dis 2002; 8:1178-82; PMID:12396935; 
http://dx.doi.org/10.3201/eid0810.020393
43. Kim K, Seo J, Wheeler K, Park C, Kim D, Park S, 
Kim W, Chung SI, Leighton T. Rapid genotypic 
detection of Bacillus anthracis and the Bacillus cereus 
group by multiplex real-time PCR melting curve anal-
ysis. FEMS Immunol Med Microbiol 2005; 43:301-
10; PMID:15681162; http://dx.doi.org/10.1016/j.
femsim.2004.10.005
44. WHO. Anthrax in humans and animals. In: Turnbull 
PC, ed. Geneva, Switzerland: WHO Press 2008.
45. Kim W, Kim JY, Cho SL, Nam SW, Shin JW, Kim 
YS, Shin HS. Glycosyltransferase: a specific marker 
for the discrimination of Bacillus anthracis from the 
Bacillus cereus group. J Med Microbiol 2008; 57:279-
86; PMID:18287289; http://dx.doi.org/10.1099/
jmm.0.47642-0
46. Létant SE, Murphy GA, Alfaro TM, Avila JR, Kane 
SR, Raber E, Bunt TM, Shah SR. Rapid-viability 
PCR method for detection of live, virulent Bacillus 
anthracis in environmental samples. Appl Environ 
Microbiol 2011; 77:6570-8; PMID:21764960; 
http://dx.doi.org/10.1128/AEM.00623-11
47. Wielinga PR, Hamidjaja RA, Agren J, Knutsson R, 
Segerman B, Fricker M, Ehling-Schulz M, de Groot 
A, Burton J, Brooks T, et al. A multiplex real-time 
PCR for identifying and differentiating B. anthracis 
virulent types. Int J Food Microbiol 2011; 145(Suppl 
1):S137-44; PMID:20826037; http://dx.doi.
org/10.1016/j.ijfoodmicro.2010.07.039
48. Oggioni MR, Meacci F, Carattoli A, Ciervo A, Orru 
G, Cassone A, Pozzi G. Protocol for real-time PCR 
identification of anthrax spores from nasal swabs after 
broth enrichment. J Clin Microbiol 2002; 40:3956-
63; PMID:12409358; http://dx.doi.org/10.1128/
JCM.40.11.3956-3963.2002
49. Ellerbrok H, Nattermann H, Ozel M, Beutin 
L, Appel B, Pauli G. Rapid and sensitive identi-
fication of pathogenic and apathogenic Bacillus 
anthracis by real-time PCR. FEMS Microbiol Lett 
2002; 214:51-9; PMID:12204372; http://dx.doi.
org/10.1111/j.1574-6968.2002.tb11324.x
50. Ko KS, Kim JM, Kim JW, Jung BY, Kim W, Kim IJ, 
Kook YH. Identification of Bacillus anthracis by rpoB 
sequence analysis and multiplex PCR. J Clin Microbiol 
2003; 41:2908-14; PMID:12843020; http://dx.doi.
org/10.1128/JCM.41.7.2908-2914.2003
51. Drago L, Lombardi A, Vecchi ED, Gismondo MR. 
Real-time PCR assay for rapid detection of Bacillus 
anthracis spores in clinical samples. J Clin Microbiol 
2002; 40:4399; PMID:12409444; http://dx.doi.
org/10.1128/JCM.40.11.4399.2002
52. Hurtle W, Bode E, Kulesh DA, Kaplan RS, Garrison 
J, Bridge D, House M, Frye MS, Loveless B, Norwood 
D. Detection of the Bacillus anthracis gyrA gene by 
using a minor groove binder probe. J Clin Microbiol 
2004; 42:179-85; PMID:14715750; http://dx.doi.
org/10.1128/JCM.42.1.179-185.2004
53. Derzelle S, Mendy C, Laroche S, Madani N. Use of 
high-resolution melting and melting temperature-
shift assays for specific detection and identification 
of Bacillus anthracis based on single nucleotide dis-
crimination. J Microbiol Methods 2011; 87:195-
201; PMID:21906635; http://dx.doi.org/10.1016/j.
mimet.2011.08.005
54. Yamada S, Ohashi E, Agata N, Venkateswaran K. 
Cloning and nucleotide sequence analysis of gyrB of 
Bacillus cereus, B. thuringiensis, B. mycoides, and B. 
anthracis and their application to the detection of B. 
cereus in rice. Appl Environ Microbiol 1999; 65:1483-
90; PMID:10103241
55. Park SH, Oh HB, Seong WK, Kim CW, Cho SY, Yoo 
CK. Differential analysis of Bacillus anthracis after 
pX01 plasmid curing and comprehensive data on 
Bacillus anthracis infection in macrophages and glial 
cells. Proteomics 2007; 7:3743-58; PMID:17880004; 
http://dx.doi.org/10.1002/pmic.200700338
56. Gierczyński R, Zasada AA, Raddadi N, Merabishvili 
M, Daffonchio D, Rastawicki W, Jagielski M. Specific 
Bacillus anthracis identification by a plcR-targeted 
restriction site insertion-PCR (RSI-PCR) assay. FEMS 
Microbiol Lett 2007; 272:55-9; PMID:17490431; 
http://dx.doi.org/10.1111/j.1574-6968.2007.00741.x
57. Irenge LM, Durant JF, Tomaso H, Pilo P, Olsen JS, 
Ramisse V, Mahillon J, Gala JL. Development and 
validation of a real-time quantitative PCR assay for 
rapid identification of Bacillus anthracis in envi-
ronmental samples. Appl Microbiol Biotechnol 
2010; 88:1179-92; PMID:20827474; http://dx.doi.
org/10.1007/s00253-010-2848-0
58. Nübel U, Schmidt PM, Reiss E, Bier F, Beyer W, 
Naumann D. Oligonucleotide microarray for identi-
fication of Bacillus anthracis based on intergenic tran-
scribed spacers in ribosomal DNA. FEMS Microbiol 
Lett 2004; 240:215-23; PMID:15522510; http://
dx.doi.org/10.1016/j.femsle.2004.09.042
59. Daffonchio D, Raddadi N, Merabishvili M, Cherif A, 
Carmagnola L, Brusetti L, Rizzi A, Chanishvili N, 
Visca P, Sharp R, et al. Strategy for identification of 
Bacillus cereus and Bacillus thuringiensis strains closely 
related to Bacillus anthracis. Appl Environ Microbiol 
2006; 72:1295-301; PMID:16461679; http://dx.doi.
org/10.1128/AEM.72.2.1295-1301.2006
60. Hadjinicolaou AV, Demetriou VL, Hezka J, Beyer W, 
Hadfield TL, Kostrikis LG. Use of molecular beacons 
and multi-allelic real-time PCR for detection of and 
discrimination between virulent Bacillus anthra-
cis and other Bacillus isolates. J Microbiol Methods 
2009; 78:45-53; PMID:19379778; http://dx.doi.
org/10.1016/j.mimet.2009.04.005
61. Zasada AA, Gierczynski R, Raddadi N, Daffonchio 
D, Jagielski M. Some Bacillus thuringiensis strains 
share rpoB nucleotide polymorphisms also present in 
Bacillus anthracis. J Clin Microbiol 2006; 44:1606-
7; PMID:16597912; http://dx.doi.org/10.1128/
JCM.44.4.1606-1607.2006
62. Sacchi CT, Whitney AM, Mayer LW, Morey R, 
Steigerwalt A, Boras A, Weyant RS, Popovic T. 
Sequencing of 16S rRNA gene: a rapid tool for iden-
tification of Bacillus anthracis. Emerg Infect Dis 
2002; 8:1117-23; PMID:12396926; http://dx.doi.
org/10.3201/eid0810.020391
63. Bourque SN, Valero JR, Lavoie MC, Levesque RC. 
Comparative Analysis of the 16S to 23S Ribosomal 
Intergenic Spacer Sequences of Bacillus thuringien-
sis Strains and Subspecies and of Closely Related 
Species. Appl Environ Microbiol 1995; 61:2811; 
PMID:16535088
64. Agren J, Sundström A, Håfström T, Segerman B. 
Gegenees: fragmented alignment of multiple genomes 
for determining phylogenomic distances and genetic 
signatures unique for specified target groups. PLoS 
One 2012; 7:e39107; PMID:22723939; http://
dx.doi.org/10.1371/journal.pone.0039107
65. Lewerin SS, Elvander M, Westermark T, Hartzell 
LN, Norström AK, Ehrs S, Knutsson R, Englund S, 
Andersson AC, Granberg M, et al. Anthrax outbreak 
in a Swedish beef cattle herd--1st case in 27 years: Case 
report. Acta Vet Scand 2010; 52:7; PMID:20122147; 
http://dx.doi.org/10.1186/1751-0147-52-7
66. Sozhamannan S, Chute MD, McAfee FD, Fouts DE, 
Akmal A, Galloway DR, Mateczun A, Baillie LW, Read 
TD. The Bacillus anthracis chromosome contains four 
conserved, excision-proficient, putative prophages. 
BMC Microbiol 2006; 6:34; PMID:16600039; 
http://dx.doi.org/10.1186/1471-2180-6-34
67. OIE. Manual of Diagnostic Tests and Vaccines for 
Terrestrial Animals. 7th ed. 2012.
68. Josefsen MH, Löfström C, Hansen T, Reynisson E, 
Hoorfar J. Instrumentation and fluorescent chemis-
tries used in qPCR. In: Filion M, ed. qPCR in applied 
microbiology. Norfolk, UK: Caister Academic Press 
2012:27-52.
69. Viera AJ, Garrett JM. Understanding interobserver 
agreement: the kappa statistic. Fam Med 2005; 
37:360-3; PMID:15883903
70. AFNOR. Méthodes d’analyse en santé animale - PCR 
(réaction de polymérisation en chaîne) - Part 2: exi-
gences et recommandations pour le développement et 
la validation de la PCR en santé animale. La Plaine 
Saint-Denis, France: AFNOR, 2014.
